Cargando…
Targeted Therapy in Cardiovascular Disease: A Precision Therapy Era
Targeted therapy refers to exploiting the specific therapeutic drugs against the pathogenic molecules (a protein or a gene) or cells. The drug specifically binds to disease-causing molecules or cells without affecting normal tissue, thus enabling personalized and precision treatment. Initially, ther...
Autores principales: | Xu, Mengda, Zhang, Kailun, Song, Jiangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085499/ https://www.ncbi.nlm.nih.gov/pubmed/33935716 http://dx.doi.org/10.3389/fphar.2021.623674 |
Ejemplares similares
-
Corrigendum: Targeted therapy in cardiovascular disease: A precision therapy era
por: Xu, Mengda, et al.
Publicado: (2023) -
Biomarkers of Neurodegeneration and Precision Therapy in Retinal Disease
por: Micera, Alessandra, et al.
Publicado: (2021) -
Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology
por: Hampel, Harald, et al.
Publicado: (2019) -
Analysis of Patents Issued in China for Antihyperglycemic Therapies for Type 2 Diabetes Mellitus
por: Zhu, Wei, et al.
Publicado: (2019) -
LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases
por: Li, Zining, et al.
Publicado: (2022)